Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02422992 · ClinicalTrials.gov registry record

Haptoglobin and Iron in Parkinson's Disease

A clinical trial of Parkinson's Disease, sponsored by Bastyr University.

Completed
Registry status
342
Enrollment target
3
Study locations

NCT02422992 is a study of Parkinson's Disease that has completed, run by Bastyr University. The registered enrollment target is 342 participants, below the 640-participant average among 156 other Parkinson's Disease trials with a reported enrollment target (47% lower). The trial reports 3 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02422992, a study of Parkinson's Disease, has completed, sponsored by Bastyr University.

COMPLETED
Registry status
342 participants
Enrollment target
3
Study locations

Study Summary

This is a case/control epidemiology study to identify what are the iron-metabolism abnormalities in Parkinson's disease (PD) patients, and risk factors relevant to PD predisposition.

Conditions Studied

Parkinson's Disease

Study Locations (3)

Washington

  • Bastyr University Research Institute - Kenmore
  • University of Washington - Seattle

California

  • University of California - San Diego

Trial Details

FieldValue
Enrollment Target 342 participants
Start Date 2013-02
Est. Completion 2016-06

Sponsor

Bastyr University

19 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02422992

The ClinicalTrials.gov registry entry for NCT02422992 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 342 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 640-participant average among 156 other Parkinson's Disease trials with a reported enrollment target (47% lower). The listed sponsor is Bastyr University, which has 19 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Parkinson's Disease appearing as the primary indexed condition, and to 0 interventions.

NCT02422992 reports 3 study locations spanning 2 distinct geographic areas - top geographies include Washington, California.

Frequently Asked Questions

What is clinical trial NCT02422992 about?

NCT02422992 is a clinical study titled "Haptoglobin and Iron in Parkinson's Disease". This is a case/control epidemiology study to identify what are the iron-metabolism abnormalities in Parkinson's disease (PD) patients, and risk factors relevant to PD predisposition.

What is the current status of trial NCT02422992?

This trial is currently completed. The enrollment target is 342 participants. The study started on 2013-02. Estimated completion is 2016-06.

What conditions does trial NCT02422992 study?

This clinical trial studies the following conditions: Parkinson's Disease.

Who is sponsoring clinical trial NCT02422992?

This trial is sponsored by Bastyr University, which has 19 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02422992 being conducted?

This trial has 3 study locations across California, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Parkinson's Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Parkinson's Disease

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.